Tuberculosis-HIV Co-infection

HIV/TB coinfection is the combination of HIV and TB infection. Those with HIV have a higher risk of developing TB disease from an untreated latent TB infection than do people without HIV. TB illness is regarded as an AIDS-defining condition in patients with HIV.Conditions that constitute AIDS include infections and cancers that provide a life-threatening hazard to HIV-positive people.
HIV treatment is referred to as antiretroviral therapy (ART). HIV medications boost the immune system, preventing the spread of HIV and AIDS-related illnesses (AIDS). Treatment with HIV and TB medications minimizes the likelihood that latent TB infection may progress to TB illness in patients with HIV and latent TB infection.

    Related Conference of Tuberculosis-HIV Co-infection

    October 04-04, 2023

    6th International Conference on Rare Diseases

    Amsterdam, Netherlands
    October 09-10, 2023

    15th Euro-Global Conference on Infectious Diseases

    Zurich, Switzerland
    October 25-26, 2023

    13th International Conference on GI Disorders

    Nova Scotia, Canada
    December 07-08, 2023

    6th Pathology and Infectious Disease Conference

    Prague, Czech Republic
    February 22-23, 2024

    11th International Congress on Infectious Diseases

    Barcelona, Spain
    February 22-23, 2024

    9th Annual Summit on Rare Diseases and Orphan Drugs

    Zurich, Switzerland

    Tuberculosis-HIV Co-infection Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in